Melanie Nelson

Chevron (Australia)

Papers

2

Total Citations

11

H-Index

2

About

Melanie Nelson is a translational researcher advancing precision surgery through multimodal imaging and nanotechnology, with a focus on sentinel lymph node biopsy (SLNB) in oncology. Her work centers on developing and validating novel tracers and robotic platforms to improve staging accuracy and reduce surgical morbidity. In a landmark 2023 preclinical study, Nelson demonstrated the feasibility of sentinel node localization in the stomach using mannose-labelled magnetic nanoparticles combined with indocyanine green, achieving 7 citations for its potential to refine D2 lymphadenectomy in gastric cancer. Earlier, in 2022, she pioneered robot-assisted SLNB in the head and neck, integrating magnetic and fluorescence guidance to access multiple neck levels through a single incision—a study with 4 citations that underscores her role in merging robotics with multimodality imaging. These contributions highlight Nelson’s impact on the frontier of image-guided surgery, where her work bridges nanoparticle engineering, intraoperative navigation, and minimally invasive techniques. Her research not only enhances pathologic staging but also promises to reduce complications in complex oncologic resections, marking her as a rising leader in surgical innovation.

Research Focus

Key Achievements

2
H-Index
2
Papers
11
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Preclinical evaluation of sentinel node localization in the stomach via mannose-labelled magnetic nanoparticles and indocyanine green
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Chevron (Australia)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago